India's pharmaceutical exports rose 6.80 per cent to USD 8.10 billion in the first quarter of FY27, with vaccine shipments surging 35.68 per cent and bulk drugs and drug intermediates growing 13.84 per cent, according to data released by the Pharmaceuticals Export Promotion Council of India (Pharmexcil).

The growth was supported by a broad rise across key product categories and export markets, with Pharmexcil saying continued product diversification, regulatory compliance and expansion into new markets will be important to maintain the momentum going forward.